Although the expression of NEIL3 and the poor prognosis of the overall population of breast cancer lack statistical support, NEIL3’s low expression patients show bad prognoses trend in ER-negative patients and have statistical differences (p < 0.05). This evidence concerns the gene ESR1 and breast cancer.